For: | Wasserberg N. Interval to surgery after neoadjuvant treatment for colorectal cancer. World J Gastroenterol 2014; 20(15): 4256-4262 [PMID: 24764663 DOI: 10.3748/wjg.v20.i15.4256] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v20/i15/4256.htm |
Number | Citing Articles |
1 |
Michele Fiore, Pasquale Trecca, Luca E. Trodella, Roberto Coppola, Marco Caricato, Damiano Caputo, Alessandro Coppola, Gian M. Petrianni, Gabriele D’Ercole, Edy Ippolito, Rolando M. D’Angelillo, Sara Ramella. Factors Predicting Pathological Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer: The Experience of a Single Institution with 269 Patients (STONE-01). Cancers 2021; 13(23): 6074 doi: 10.3390/cancers13236074
|
2 |
Te-Min Ke, Li-Ching Lin, Chun-Che Huang, Yu-Wen Chien, Wei-Chen Ting, Ching-Chieh Yang. High neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio predict poor survival in rectal cancer patients receiving neoadjuvant concurrent chemoradiotherapy. Medicine 2020; 99(17): e19877 doi: 10.1097/MD.0000000000019877
|
3 |
Li Chen, Wenchao Zhu, Wei Zhang, Engeng Chen, Wei Zhou. Magnetic resonance imaging radiomics-based prediction of severe inflammatory response in locally advanced rectal cancer patients after neoadjuvant radiochemotherapy. Langenbeck's Archives of Surgery 2024; 409(1) doi: 10.1007/s00423-024-03416-7
|
4 |
Lisa Loughney, Malcolm A. West, Borislav D. Dimitrov, Graham J. Kemp, Michael PW. Grocott, Sandy Jack. Physical activity levels in locally advanced rectal cancer patients following neoadjuvant chemoradiotherapy and an exercise training programme before surgery: a pilot study. Perioperative Medicine 2017; 6(1) doi: 10.1186/s13741-017-0058-3
|
5 |
Erhan Akgun, Cemil Caliskan, Osman Bozbiyik, Tayfun Yoldas, Basak Doganavsargil, Serdar Ozkok, Timur Kose, Bulent Karabulut, Nevra Elmas, Omer Ozutemiz. Effect of interval between neoadjuvant chemoradiotherapy and surgery on disease recurrence and survival in rectal cancer: long-term results of a randomized clinical trial. BJS Open 2022; 6(5) doi: 10.1093/bjsopen/zrac107
|
6 |
Benjamin M. Mac Curtain, Wanyang Qian, Aaron O’Mahony, Avinash Deshwal, Reuben D. Mac Curtain, Hugo C. Temperley, Niall O. Sullivan, Zi Qin Ng. “Textbook outcome(s)” in colorectal surgery: a systematic review and meta-analysis. Irish Journal of Medical Science (1971 -) 2024; 193(5): 2187 doi: 10.1007/s11845-024-03747-w
|
7 |
Serdar Karakaya, İbrahim Karadağ, Mehmet Emin Yılmaz, Ömür Berna Çakmak Öksüzoğlu. High Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio and Low Lymphocyte Levels Are Correlated With Worse Pathological Complete Response Rates. Cureus 2022; doi: 10.7759/cureus.22972
|
8 |
Farnaz Karimi, Hedieh Moradi Tabriz, Hadi Ahmadi Amoli, Elham Nazar, Amir Abbas Vaezi. Evaluation of the histopathologic status of rectal adenocarcinoma and its regional lymph nodes after neoadjuvant therapy, and its relation to the duration of disease-free survival. Indian Journal of Pathology and Microbiology 2022; 65(1): 49 doi: 10.4103/IJPM.IJPM_1331_20
|
9 |
Tamara G. Mullaney, Amy L. Lightner, Michael Johnston, James Keck, David Wattchow. ‘Watch and wait’ after chemoradiotherapy for rectal cancer. ANZ Journal of Surgery 2018; 88(9): 836 doi: 10.1111/ans.14352
|
10 |
E.A. Sánchez-Pérez, J.A. Villanueva-Herrero, M.D. Sandoval-Martínez, B. Jiménez-Bobadilla. Complete pathological response after neoadjuvant therapy in patients with rectal adenocarcinoma. Revista Médica del Hospital General de México 2017; 80(4): 212 doi: 10.1016/j.hgmx.2017.06.001
|
11 |
Sea-Won Lee, Jong Hoon Lee, In Kyu Lee, Seong Taek Oh, Dae Yong Kim, Tae Hyun Kim, Jae Hwan Oh, Ji Yeon Baek, Hee Jin Chang, Hee Chul Park, Hee Cheol Kim, Eui Kyu Chie, Taek-Keun Nam, Hong Seok Jang. The Impact of Surgical Timing on Pathologic Tumor Response after Short Course and Long Course Preoperative Chemoradiation for Locally Advanced Rectal Adenocarcinoma. Cancer Research and Treatment 2018; 50(3): 1039 doi: 10.4143/crt.2017.252
|
12 |
Victor Duque-Santana, Fernando López-Campos, Margarita Martin-Martin, Mireia Valero, Juan Zafra-Martín, Felipe Couñago, Sonsoles Sancho. Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Factors in Locally Advanced Rectal Cancer. Oncology 2023; 101(6): 349 doi: 10.1159/000526450
|
13 |
E. Hannan, M. E. Kelly, M. R. Fahy, D. C. Winter. Prehabilitation in rectal surgery: a narrative review. International Journal of Colorectal Disease 2022; 37(2): 293 doi: 10.1007/s00384-021-04092-5
|
14 |
Bo P Smalbroek, Teus J Weijs, Lea M Dijksman, Floris B Poelmann, Lucas Goense, Robert R Dijkstra, Niels A T Wijffels, Djamila Boerma, Anke B Smits, F J Amelung, E C J Consten, T A Burghgraef, D A Hess, R Roukema, A Demirkiran, M Tenhagen, J Straatman, G Nieuwenhuijzen, H J T Rutten, G Vugts, B Inberg, A Kreiter, S Scheurs, M F Gerhards, R L G M Blom, M J A M Russchen, A van den Berg, J W T Dekker, H P Versteegh, F W H Kloppenberg, I S Bakker, J T H Hamminga, J L M Konsten, M van Heinsbergen, S T van Vugt, J E Bouwman, J T Heikens, A van den Berg, M Takkenberg, L Graat, A J N M Bastiaansen, E A Gorter, J W S Merkus, E G Boerma, L Koolen, D Jean Pierre, E van der Harst, W Hogendoorn, L H Wijngaarden, R T J kortekaas, M C Struijs, N Heuchemer, P Fockens, E E van Halsema, W A A Borstlap, P J Tanis, J Veld, W A Bemelman, D D Wisselink, A C H M Jongen, V N E Schuermans, N D Bouvy, C S Andeweg, J W Foppen, J Heemskerk, J Scheerhoorn, P van der Sluis, N Smakman, E R J Bruns, E S van der Zaag, H J Schuiten, T Argillander, K Parry, D Lips, H Algera, P Poortman, C Steur, H A Swank, B Lamme, M N N J Arron, D van Uden, P D Siersema, J H W de Wilt, L Daniels, D J A Sonneveld, K Nielsen, I Masselink, L M Lutke Holzik, G Lo, A G Menon, J F Lange, B J van Wely, A van Esch, D E Moes, B M M Reuber, B H M Heijnen, I de Groot-van Veen, A W H van de Ven, C C M Marres, H E Haak, M Vermaas, P van Hagen, H L van Westreenen, J W A de Haas, J M Klaase, M J F van Veen, A Mearadji, J Heeren, R Silvis, J A M G Tol, C J L Molenaar, J A van Essen, T Lettinga, L Verkoele, G L Beets, D D E Zimmerman, Y T van Loon, P Oomen, H S de Vries, J E van Hooft, K C M J Peeters, N D A Boye, F ter Borg, A K Talsma, A A Wijkmans, A A W van Geloven, N van Oorschot, B Blomberg, W M U van Grevenstein, J L Tolenaar, F C den Boer, J C Sierink, T Paulides, B M M Reiber, B van de Beukel, J B Tuynman, H T Bransma, A R M Brandt-Kerkhof, M E E Bröker, R M P H Crolla, J van der Slegt, T L Janssen, C Werker, H J Schuijt, M J Wiezer, K van Dongen, V Kornmann, L Tseng, D Smit, C Sietses, T Visser, G D Algie, M J Nieboer, P A Neijenhuis, S F Durmaz, T H J Aufenacker, N Hugen, M van Basten Batenburg, M Westerterp, J van Groningen, W J de Jong, R J Renger, F Logeman, G Slooter, K Arts, J Wegdam, G Meisen, B Wiering, H C J van der Mijle, I Paulusma, M van der Sluis, K Havenga, J P M Burbach, E J B Furnee, B Polle, C Hoff, F Poelmann, T L R Zwols, T C van Sprundel, S C Veltkamp, M van de Wilt, W J Vles, A Kamman, H Schippers, R L van der Hul, A Breijer, W Kelder, B van den Hengel, R Klicks, E F Kelling, A P J Houdijk, L Heijnen, F Wit, M Dam, M Raber, D J L M de Mey, W van den Broek, L Verslijs, G W de Klein, W M J de Ruijter, R de Vos tot Nederveen Cappel. Use of ileostomy versus colostomy as a bridge to surgery in left-sided obstructive colon cancer: retrospective cohort study. BJS Open 2023; 7(3) doi: 10.1093/bjsopen/zrad038
|
15 |
Katharina Joechle, Eleni Gkika, Anca-Ligia Grosu, Sven A. Lang, Stefan Fichtner-Feigl. Intraoperative Strahlentherapie – Indikationen und Optionen in der Viszeralchirurgie. Der Chirurg 2020; 91(9): 743 doi: 10.1007/s00104-020-01179-7
|
16 |
Pedja Cuk, Randi Maria Simonsen, Mirjana Komljen, Michael Festersen Nielsen, Per Helligsø, Andreas Kristian Pedersen, Christian Backer Mogensen, Mark Bremholm Ellebæk. Improved perioperative outcomes and reduced inflammatory stress response in malignant robot-assisted colorectal resections: a retrospective cohort study of 298 patients. World Journal of Surgical Oncology 2021; 19(1) doi: 10.1186/s12957-021-02263-w
|
17 |
Britt J. P. Hupkens, Geerard L. Beets. Multidisciplinary Management of Rectal Cancer. 2018; : 485 doi: 10.1007/978-3-319-43217-5_57
|
18 |
F.A. Holman, S.J. Bosman, M.G. Haddock, L.L. Gunderson, M. Kusters, G.A.P. Nieuwenhuijzen, H. van den Berg, H. Nelson, H.J. Rutten. Results of a pooled analysis of IOERT containing multimodality treatment for locally recurrent rectal cancer. European Journal of Surgical Oncology (EJSO) 2017; 43(1): 107 doi: 10.1016/j.ejso.2016.08.015
|
19 |
Maria Emilia Carvalho e Carvalho, Bruno Augusto Alves-Martins, Luiz Felipe de Campos-Lobato. Current Views on the Interval Between Neoadjuvant Chemoradiation and Surgery for Rectal Cancer. Current Colorectal Cancer Reports 2017; 13(3): 234 doi: 10.1007/s11888-017-0370-9
|
20 |
Yeen Chin Leow, April Camilla Roslani, Ruben Gregory Xavier, Fei Yee Lee. Pathological Complete Response After Neoadjuvant Therapy in Rectal Adenocarcinoma: a 5-Year Follow-up. Indian Journal of Surgery 2021; 83(S3): 768 doi: 10.1007/s12262-021-02945-5
|
21 |
Robin Detering, Wernard A. A. Borstlap, Lisa Broeders, Linda Hermus, Corrie A. M. Marijnen, Regina G. H. Beets-Tan, Willem A. Bemelman, Henderik L. van Westreenen, Pieter J. Tanis. Cross-Sectional Study on MRI Restaging After Chemoradiotherapy and Interval to Surgery in Rectal Cancer: Influence on Short- and Long-Term Outcomes. Annals of Surgical Oncology 2019; 26(2): 437 doi: 10.1245/s10434-018-07097-7
|
22 |
Niamh O’ Halloran, Terri McVeigh, Joseph Martin, Maccon Keane, Aoife Lowery, Michael Kerin. Neoadjuvant chemoradiation and breast reconstruction: the potential for improved outcomes in the treatment of breast cancer. Irish Journal of Medical Science (1971 -) 2019; 188(1): 75 doi: 10.1007/s11845-018-1846-6
|
23 |
Jii Bum Lee, Han Sang Kim, Inkyung Jung, Sang Joon Shin, Seung Hoon Beom, Jee Suk Chang, Woong Sub Koom, Tae Il Kim, Hyuk Hur, Byung Soh Min, Nam Kyu Kim, Sohee Park, Seung-Yong Jeong, Jeong-Heum Baek, Seon Hahn Kim, Joon Seok Lim, Kang Young Lee, Joong Bae Ahn. Upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy for locally advanced rectal cancer (TME-FOLFOX): an open-label, multicenter, phase II randomized controlled trial. Trials 2020; 21(1) doi: 10.1186/s13063-020-04266-6
|
24 |
M.‐H. Hu, R.‐K. Huang, R.‐S. Zhao, K.‐L. Yang, H. Wang. Does neoadjuvant therapy increase the incidence of anastomotic leakage after anterior resection for mid and low rectal cancer? A systematic review and meta‐analysis. Colorectal Disease 2017; 19(1): 16 doi: 10.1111/codi.13424
|
25 |
Daniela Rega, Biagio Pecori, Dario Scala, Antonio Avallone, Ugo Pace, Antonella Petrillo, Luigi Aloj, Fabiana Tatangelo, Paolo Delrio, José A. Morgado-Díaz. Evaluation of Tumor Response after Short-Course Radiotherapy and Delayed Surgery for Rectal Cancer. PLOS ONE 2016; 11(8): e0160732 doi: 10.1371/journal.pone.0160732
|
26 |
Nathalie Guedj, Léon Maggiori, Nicolas Poté, Emma Norkowski, Jérôme Cros, Pierre Bedossa, Yves Panis. Distal intramural and tumor spread in the mesorectum after neoadjuvant radiochemotherapy in rectal cancer: about 124 consecutive patients. Human Pathology 2016; 52: 164 doi: 10.1016/j.humpath.2016.01.017
|
27 |
Magdalena Pisarska-Adamczyk, Tomasz Stefura, Piotr Małczak, Piotr Major, Michał Wysocki. Is It Possible to Predict Difficulties During Laparoscopic Sleeve Gastrectomy? A Single Centre Experience. Journal of Personalized Medicine 2024; 14(11): 1098 doi: 10.3390/jpm14111098
|
28 |
Cory Pettit, Amy Webb, Steve Walston, Moumita Chatterjee, Wei Chen, Wendy Frankel, Carlo Croce, Terence M. Williams. MicroRNA molecular profiling identifies potential signaling pathways conferring resistance to chemoradiation in locally-advanced rectal adenocarcinoma. Oncotarget 2018; 9(48): 28951 doi: 10.18632/oncotarget.25652
|
29 |
Jii Bum Lee, Han Sang Kim, Ahrong Ham, Jee Suk Chang, Sang Jun Shin, Seung-Hoon Beom, Woong Sub Koom, Taeil Kim, Yoon Dae Han, Dai Hoon Han, Hyuk Hur, Byung Soh Min, Kang Young Lee, Nam Kyu Kim, Yu Rang Park, Joon Seok Lim, Joong Bae Ahn. Role of Preoperative Chemoradiotherapy in Clinical Stage II/III Rectal Cancer Patients Undergoing Total Mesorectal Excision: A Retrospective Propensity Score Analysis. Frontiers in Oncology 2021; 10 doi: 10.3389/fonc.2020.609313
|
30 |
Margaret Lee, Peter Gibbs, Rachel Wong. Multidisciplinary Management of Locally Advanced Rectal Cancer—An Evolving Landscape?. Clinical Colorectal Cancer 2015; 14(4): 251 doi: 10.1016/j.clcc.2015.06.002
|
31 |
Geerard L. Beets, Nuno F. Figueiredo, Regina G.H. Beets-Tan. Management of Rectal Cancer Without Radical Resection. Annual Review of Medicine 2017; 68(1): 169 doi: 10.1146/annurev-med-062915-021419
|
32 |
Dirk Vande Putte, Yves Van Nieuwenhove, Wouter Willaert, Piet Pattyn, Wim Ceelen. Organ preservation in rectal cancer: current status and future perspectives. Colorectal Cancer 2015; 4(4): 185 doi: 10.2217/crc.15.18
|
33 |
A. J. M. Rombouts, N. Hugen, M. A. G. Elferink, I. D. Nagtegaal, J. H. W. de Wilt. Treatment Interval between Neoadjuvant Chemoradiotherapy and Surgery in Rectal Cancer Patients: A Population-Based Study. Annals of Surgical Oncology 2016; 23(11): 3593 doi: 10.1245/s10434-016-5294-0
|
34 |
Sebastian Curcean, Andra Curcean, Daniela Martin, Zsolt Fekete, Alexandru Irimie, Alina-Simona Muntean, Cosmin Caraiani. The Role of Predictive and Prognostic MRI-Based Biomarkers in the Era of Total Neoadjuvant Treatment in Rectal Cancer. Cancers 2024; 16(17): 3111 doi: 10.3390/cancers16173111
|
35 |
A. O. Rasulov, S. S. Gordeyev, Yu. A. Barsukov, S. I. Tkachev, A. G. Malikhov, S. S. Balyasnikova, M. Yu. Fedyanin. Short-course preoperative radiotherapy combined with chemotherapy, delayed surgery and local hyperthermia for rectal cancer: a phase II study. International Journal of Hyperthermia 2017; 33(4): 465 doi: 10.1080/02656736.2016.1272138
|
36 |
Lisa Loughney, Malcolm A. West, Graham J. Kemp, Harry B. Rossiter, Shaunna M. Burke, Trevor Cox, Christopher P. Barben, Michael G. Mythen, Peter Calverley, Daniel H. Palmer, Michael P. W. Grocott, Sandy Jack. The effects of neoadjuvant chemoradiotherapy and an in-hospital exercise training programme on physical fitness and quality of life in locally advanced rectal cancer patients (The EMPOWER Trial): study protocol for a randomised controlled trial. Trials 2016; 17(1) doi: 10.1186/s13063-015-1149-4
|
37 |
Satoshi Murahashi, Takashi Akiyoshi, Takeshi Sano, Yosuke Fukunaga, Tetsuo Noda, Masashi Ueno, Hitoshi Zembutsu. Serial circulating tumour DNA analysis for locally advanced rectal cancer treated with preoperative therapy: prediction of pathological response and postoperative recurrence. British Journal of Cancer 2020; 123(5): 803 doi: 10.1038/s41416-020-0941-4
|